scispace - formally typeset
L

Luisa M. Villar

Researcher at Hospital Universitario de Canarias

Publications -  171
Citations -  5108

Luisa M. Villar is an academic researcher from Hospital Universitario de Canarias. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 35, co-authored 152 publications receiving 4039 citations. Previous affiliations of Luisa M. Villar include University Hospital of Basel & University of Málaga.

Papers
More filters
Journal ArticleDOI

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Claire Bridel, +82 more
- 01 Sep 2019 - 
TL;DR: The cNfL increased with age in HC and a majority of neurological conditions, although the association was strongest in HC, and has potential to assist the differentiation of FTD from AD and PD from atypical parkinsonian syndromes.
Journal ArticleDOI

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis

TL;DR: Although protein levels are also increased in other disorders characterized by chronic inflammation, chitinase 3-like 1 may serve as a prognostic biomarker for conversion to multiple sclerosis and development of disability which may help to improve the understanding of the aetiopathogenesis in the early stages of multiple sclerosis.
Journal ArticleDOI

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Jens Kuhle, +98 more
TL;DR: MRI lesion load, OCB and age at CIS are validated as the strongest independent predictors of conversion to CDMS in this multicentre setting.
Journal ArticleDOI

Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS

TL;DR: The presence of intrathecal anti-myelin lipid IgM antibodies is a very accurate predictor of aggressive evolution in MS and the relationship between specificity and disease evolution is explored.
Journal ArticleDOI

Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis

TL;DR: The follow‐up of a group of relapsing‐remitting MS patients for a longer time to evaluate whether the ITMS implies a poor prognosis, and the presence of oligoclonal IgM bands in cerebrospinal fluid is an unfavorable prognostic marker in MS.